LifeVantage today announced the Board of Directors has approved the appointment of Carrie Carlander as Chief Financial Officer.
Ms. Carlander most recently served as Chief Financial Officer of Genelux Corporation. Prior to Genelux, Ms. Carlander served as Chief Financial Officer for Adventrx Pharmaceuticals. She has also served in the role of Vice President Finance for V-Enable, Inc. and Websense Inc. Ms. Carlander has an MBA in Finance and Management from San Diego State University, a Bachelorâ€™s Degree from the University of California at San Diego and is a Certified Management Accountant.
â€œI am very pleased that Carrie has joined LifeVantage,â€ said David W. Brown, President and CEO of LifeVantage Corporation. â€œHer impressive background and track record with dynamic public companies and her proven abilities in corporate governance, strategic planning, investor relations, and finance, will be a tremendous asset to LifeVantage.â€
â€œI am excited and honored to join the LifeVantage team, as I feel this is a company with tremendous growth potential. I look forward to joining David and the rest of the management team in building upon the great momentum the Company has recently generated through its launch into the network marketing channel and its rapid attraction of thousands of independent distributors,â€ said Ms. Carlander.
Logo from LifeVantage